US2022142735A1PendingUtilityA1

Bleeding control device and method of manufacture and use

Individually held — no corporate assignee on recordPriority: Feb 10, 2020Filed: Jan 23, 2022Published: May 12, 2022
Est. expiryFeb 10, 2040(~13.5 yrs left)· nominal 20-yr term from priority
Inventors:Ryan L. Reese
A61C 5/40A61L 2300/418A61L 2400/04A61L 2430/12A61L 24/0015A61K 47/38A61K 31/137A61K 47/10A61K 9/0048A61K 6/52A61K 6/50
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A bleeding control device is provided. The device includes an elongate member with a holding portion and an application portion. A known amount of hemostatic solute within a solution is administered to the application portion and allowed to dry. The elongate member is then sterilized. The resulting bleeding control device may be used during medical procedures such as root canal procedures and others.

Claims

exact text as granted — not AI-modified
1 . A method of making a bleeding control device, the method comprising:
 (A) providing an elongate applicator comprising cellulose and including a first end and a second end and an application portion extending from the second end to an intermediate location between the first end and the second end;   (B) forming a solution comprising a hemostatic agent solute including epinephrine;   (C) administering a volume of the solution to the application portion;   (D) allowing the application portion to dry;   (E) sterilizing the bleeding control device using an autoclave; and   (F) allowing the sterilized bleeding control device from (E) to dry using a holder.   
     
     
         2 . The method of  claim 1  further comprising:
 (G) providing the bleeding control device for use during a dental procedure. 
 
     
     
         3 . The method of  claim 2  wherein the dental procedure includes a root canal procedure. 
     
     
         4 . The method of  claim 1  wherein the volume includes about 2.5 μ-liters to 5 μ-liters of solution total. 
     
     
         5 . The method of  claim 1  wherein the solution total volume includes about 0.3 mg-1.5 mg of the epinephrine total. 
     
     
         6 . The method of  claim 1  wherein the sterilizing the bleeding control device in (E) includes sterilizing the bleeding control device within the autoclave at about 250° F. for about 20 minutes. 
     
     
         7 . The method of  claim 1  wherein the administering the volume of the solution to the application portion in (C) includes using a single- or multi-channel micropipette. 
     
     
         8 . The method of  claim 7  wherein the micropipette includes a volume range of about 0.5 μ-liters to 10 μ-liters. 
     
     
         9 . The method of  claim 1  wherein the applicator includes a holder portion extending from the first end to the intermediate location. 
     
     
         10 . The method of  claim 9  wherein the holder portion is kept free of solution. 
     
     
         11 . The method of  claim 1  wherein the applicator is tapered. 
     
     
         12 . The method of  claim 1  wherein the application portion is tapered. 
     
     
         13 . The method of  claim 1  wherein the elongate applicator includes a core extending at least partially between the first end and the second end and that provides rigidity to the elongate applicator. 
     
     
         14 . The method of  claim 1  wherein the elongate applicator includes at least one depth indicating mark.

Join the waitlist — get patent alerts

Track US2022142735A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.